Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015

Imagem de Miniatura
Arquivos
art_WANG_Global_regional_and_national_life_expectancy_allcause_mortality_2016.PDF (23.31 MB)
Citações na Scopus
4972
Tipo de produção
article
Data de publicação
2016
Editora
ELSEVIER SCIENCE INC
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
WANG, Haidong
NAGHAVI, Mohsen
ALLEN, Christine
BARBER, Ryan M.
BHUTTA, Zulfiqar A.
CARTER, Austin
CASEY, Daniel C.
CHARLSON, Fiona J.
CHEN, Alan Zian
COATES, Matthew M.
Autor de Grupo de pesquisa
GBD 015 Mortality and Causes Death
Editores
Coordenadores
Organizadores
Citação
LANCET, v.388, n.10053, p.1459-1544, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015. These results informed an in-depth investigation of observed and expected mortality patterns based on sociodemographic measures. Methods We estimated all-cause mortality by age, sex, geography, and year using an improved analytical approach originally developed for GBD 2013 and GBD 2010. Improvements included refinements to the estimation of child and adult mortality and corresponding uncertainty, parameter selection for under-5 mortality synthesis by spatiotemporal Gaussian process regression, and sibling history data processing. We also expanded the database of vital registration, survey, and census data to 14 294 geography-year datapoints. For GBD 2015, eight causes, including Ebola virus disease, were added to the previous GBD cause list for mortality. We used six modelling approaches to assess cause-specific mortality, with the Cause of Death Ensemble Model (CODEm) generating estimates for most causes. We used a series of novel analyses to systematically quantify the drivers of trends in mortality across geographies. First, we assessed observed and expected levels and trends of cause-specific mortality as they relate to the Socio-demographic Index (SDI), a summary indicator derived from measures of income per capita, educational attainment, and fertility. Second, we examined factors affecting total mortality patterns through a series of counterfactual scenarios, testing the magnitude by which population growth, population age structures, and epidemiological changes contributed to shifts in mortality. Finally, we attributed changes in life expectancy to changes in cause of death. We documented each step of the GBD 2015 estimation processes, as well as data sources, in accordance with Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER). Findings Globally, life expectancy from birth increased from 61.7 years (95% uncertainty interval 61.4-61.9) in 1980 to 71.8 years (71.5-72.2) in 2015. Several countries in sub-Saharan Africa had very large gains in life expectancy from 2005 to 2015, rebounding from an era of exceedingly high loss of life due to HIV/AIDS. At the same time, many geographies saw life expectancy stagnate or decline, particularly for men and in countries with rising mortality from war or interpersonal violence. From 2005 to 2015, male life expectancy in Syria dropped by 11.3 years (3.7-17.4), to 62.6 years (56.5-70.2). Total deaths increased by 4.1% (2.6-5.6) from 2005 to 2015, rising to 55.8 million (54.9 million to 56.6 million) in 2015, but age-standardised death rates fell by 17.0% (15.8-18.1) during this time, underscoring changes in population growth and shifts in global age structures. The result was similar for non-communicable diseases (NCDs), with total deaths from these causes increasing by 14.1% (12.6-16.0) to 39.8 million (39.2 million to 40.5 million) in 2015, whereas age-standardised rates decreased by 13.1% (11.9-14.3). Globally, this mortality pattern emerged for several NCDs, including several types of cancer, ischaemic heart disease, cirrhosis, and Alzheimer's disease and other dementias. By contrast, both total deaths and age-standardised death rates due to communicable, maternal, neonatal, and nutritional conditions significantly declined from 2005 to 2015, gains largely attributable to decreases in mortality rates due to HIV/AIDS (42.1%, 39.1-44.6), malaria (43.1%, 34.7-51.8), neonatal preterm birth complications (29.8%, 24.8-34.9), and maternal disorders (29.1%, 19.3-37.1). Progress was slower for several causes, such as lower respiratory infections and nutritional deficiencies, whereas deaths increased for others, including dengue and drug use disorders. Age-standardised death rates due to injuries significantly declined from 2005 to 2015, yet interpersonal violence and war claimed increasingly more lives in some regions, particularly in the Middle East. In 2015, rotaviral enteritis (rotavirus) was the leading cause of under-5 deaths due to diarrhoea (146 000 deaths, 118 000-183 000) and pneumococcal pneumonia was the leading cause of under-5 deaths due to lower respiratory infections (393 000 deaths, 228 000-532 000), although pathogen-specific mortality varied by region. Globally, the effects of population growth, ageing, and changes in age-standardised death rates substantially differed by cause. Our analyses on the expected associations between cause-specific mortality and SDI show the regular shifts in cause of death composition and population age structure with rising SDI. Country patterns of premature mortality (measured as years of life lost [YLLs]) and how they differ from the level expected on the basis of SDI alone revealed distinct but highly heterogeneous patterns by region and country or territory. Ischaemic heart disease, stroke, and diabetes were among the leading causes of YLLs in most regions, but in many cases, intraregional results sharply diverged for ratios of observed and expected YLLs based on SDI. Communicable, maternal, neonatal, and nutritional diseases caused the most YLLs throughout sub-Saharan Africa, with observed YLLs far exceeding expected YLLs for countries in which malaria or HIV/AIDS remained the leading causes of early death. Interpretation At the global scale, age-specific mortality has steadily improved over the past 35 years; this pattern of general progress continued in the past decade. Progress has been faster in most countries than expected on the basis of development measured by the SDI. Against this background of progress, some countries have seen falls in life expectancy, and age-standardised death rates for some causes are increasing. Despite progress in reducing age-standardised death rates, population growth and ageing mean that the number of deaths from most non-communicable causes are increasing in most countries, putting increased demands on health systems.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/18751
Referências
  1. AbouZahr C, 2015, LANCET, V386, P1373, DOI 10.1016/S0140-6736(15)60173-8
  2. AbouZahr C, 2015, LANCET, V386, P1407, DOI 10.1016/S0140-6736(15)60170-2
  3. Abu-Zidan FM, 2012, WORLD J SURG, V36, P255, DOI 10.1007/s00268-011-1386-y
  4. Agua-Agum J, 2015, NEW ENGL J MED, V372, P584, DOI DOI 10.1056/NEJMC1414992
  5. Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323
  6. Bhalla K, 2015, INT J EPIDEMIOL, V44, P1648, DOI 10.1093/ije/dyv019
  7. Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
  8. Bidell MR, 2016, INFECT DIS THER, DOI [10.1007/s40121-016-0118-x, DOI 10.1007/S40121-016-0118-X.]
  9. Birnbaum JK, 2011, B WORLD HEALTH ORGAN, V89, P278, DOI 10.2471/BLT.11.086280
  10. Bishai D, 2006, HEALTH ECON, V15, P65, DOI 10.1002/hec.1020
  11. Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207
  12. Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544
  13. Bunn F, 2003, INJURY PREV, V9, P200, DOI 10.1136/ip.9.3.200
  14. Burnham G, 2006, HUMAN COST WAR IRAQ
  15. Burnham G, 2006, SCIENCE, V314, P1241
  16. Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9
  17. Butchart A, 2014, GLOBAL STATUS REPORT
  18. CALDWELL JC, 1986, POPUL DEV REV, V12, P171, DOI 10.2307/1973108
  19. Coale AJ, 1966, REGIONAL MODEL LIFE
  20. Cummings P, 2006, INJURY PREV, V12, P148, DOI 10.1136/ip.2005.010975
  21. Cusimano MD, 2011, INJURY PREV, V17, P43, DOI 10.1136/ip.2009.025502
  22. Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97
  23. Darke S, 2010, DRUG ALCOHOL REV, V29, P202, DOI 10.1111/j.1465-3362.2009.00099.x
  24. Deaton A, 2003, J ECON LIT, V41, P113, DOI 10.1257/002205103321544710
  25. Department of Peace and Conflict Research, UPPS CONFL DAT PROGR
  26. Dieleman JL, 2015, JAMA-J AM MED ASSOC, V313, P2359, DOI 10.1001/jama.2015.5825
  27. Duncan ME, 2014, EUROPACE, V16, P797, DOI 10.1093/europace/eut388
  28. Eaton J., READ EPP SPECTRUM
  29. ENSR, 2008, NAT ROAD SAF STRAT 2
  30. Farmer PE, 2013, NEW ENGL J MED, V369, P2424, DOI 10.1056/NEJMsa1310472
  31. Feikin DR, 2014, LANCET, V383, P1762, DOI 10.1016/S0140-6736(13)61682-7
  32. Fekadu A, 2015, BRIT J PSYCHIAT, V206, P289, DOI 10.1192/bjp.bp.114.149112
  33. Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
  34. Ferrari AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091936
  35. Flaxman AD, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0061-1
  36. Flaxman AD, 2015, INTEGRATIVE METAREGR
  37. Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1
  38. Forouzanfar MH, 2016, LANCET, V388, P1659
  39. Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2
  40. Garcia-Garcia G, 2005, KIDNEY INT, V68, pS58, DOI 10.1111/j.1523-1755.2005.09710.x
  41. Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
  42. The GATHER Working Group, 2016, LANCET
  43. Gomez-Dantes H, 2016, LANCET
  44. Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799
  45. Guha-Sapir D., EM DAT CRED OFDA INT
  46. Das Gupta P., 1993, STANDARDIZATION DECO
  47. Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616
  48. Hahn RA, 2005, AM J PREV MED, V28, P40, DOI 10.1016/j.amepre.2004.10.005
  49. Helleringer S, 2014, DEMOGRAPHY, V51, P387, DOI 10.1007/s13524-013-0268-3
  50. Hill K, 2015, LANCET GLOB HEALTH, V3, pE609, DOI 10.1016/S2214-109X(15)00044-3
  51. Hill K, 2009, DEMOGR RES, V21, P235, DOI 10.4054/DemRes.2009.21.9
  52. Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1
  53. Hyder AA, 2014, B WORLD HEALTH ORGAN, V92, P423, DOI 10.2471/BLT.13.132613
  54. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans International Agency for Research on Cancer, 2012, REV HUM CARC
  55. The International Institute for Strategic Studies, ARM CONFL DAT
  56. [Anonymous], HAND GLOB PROGR UN E
  57. JH Bloomberg School of Public Health, MAT CHILD EP EST
  58. Jonker FAM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001555
  59. Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6
  60. Komenda P, 2014, AM J KIDNEY DIS, V63, P789, DOI 10.1053/j.ajkd.2013.12.012
  61. Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
  62. Kuhns JB, 2013, HOMICIDE STUD
  63. Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788
  64. Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853
  65. Leavy JE, 2015, J COMMUN HEALTH, V40, P725, DOI 10.1007/s10900-015-9991-6
  66. Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
  67. Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X
  68. Liu J, 2014, LANCET INFECT DIS, V14, P716, DOI 10.1016/S1473-3099(14)70808-4
  69. Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12
  70. Lo S, 2015, LANCET, V386, P106, DOI 10.1016/S0140-6736(15)61040-6
  71. Lonnroth K, 2014, LANCET DIABETES ENDO, V2, P730, DOI 10.1016/S2213-8587(14)70109-3
  72. Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
  73. Lopez AD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0333-4
  74. Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
  75. Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-50
  76. Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816
  77. Lunyera J, 2016, CLIN J AM SOC NEPHRO, V11, P379, DOI 10.2215/CJN.07500715
  78. Luoma J, 2012, ROAD SAFETY MANAGEME
  79. Malhotra J, 2016, EUR RESPIR J, V48, P889, DOI 10.1183/13993003.00359-2016
  80. Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064
  81. Manolio TA, 2013, GENET MED, V15, P258, DOI 10.1038/gim.2012.157
  82. Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6
  83. McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3
  84. Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141
  85. Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
  86. Motohashi Y, 2007, SUICIDE LIFE-THREAT, V37, P593, DOI 10.1521/suli.2007.37.5.593
  87. Murray C, 1996, GLOBAL BURDEN DIS CO
  88. Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8
  89. Murray CJL, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-5
  90. Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6
  91. Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4
  92. Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262
  93. Murray C. J., 2015, LANCET
  94. Murray CJL, 2003, POP STUD-J DEMOG, V57, P165, DOI 10.1080/0032472032000097083
  95. Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4
  96. Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
  97. Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
  98. Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9
  99. Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6
  100. Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X
  101. Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260
  102. Olfson M, 2015, JAMA PSYCHIAT, V72, P1172, DOI 10.1001/jamapsychiatry.2015.1737
  103. OLSHANSKY SJ, 1986, MILBANK Q, V64, P355, DOI 10.2307/3350025
  104. OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375
  105. Osby U, 2016, EUR J PUBLIC HEALTH, DOI [10.1093/eurpub/ckv245, DOI 10.1093/EURPUB/CKV245.]
  106. Ozyilmaz A, 2012, NEPHROL DIAL TRANSPL, V27, P4046, DOI 10.1093/ndt/gfs438
  107. Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
  108. Perez K, 2007, AM J PUBLIC HEALTH, V97, P1632, DOI 10.2105/AJPH.2006.093195
  109. Peterson HM, 2013, LANCET, V381, P110
  110. PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509
  111. Public Health England, 2014, EV ACT OPP PROT IMPR
  112. Qian MB, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-4
  113. Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X
  114. Ramsey R, 2012, PUBLIC HEALTH NUTR, V15, P227, DOI 10.1017/S1368980011001996
  115. [Anonymous], STRAUSS CTR INT SECU
  116. Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a
  117. Roulson J, 2005, HISTOPATHOLOGY, V47, P551, DOI 10.1111/j.1365-2559.2005.02243.x
  118. Rudan I, 2015, LANCET, V385, P92, DOI 10.1016/S0140-6736(14)62006-7
  119. Sahoo SK, 2012, NANOTECHNOLOGY HLTH
  120. Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327
  121. Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1
  122. Schneider MT, 2016, AIDS, V30, P1475, DOI 10.1097/QAD.0000000000001081
  123. Serina P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0528-8
  124. Dinesh Shah A, 2015, LANCET S1, V385, pS86
  125. Shallcross LJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0082
  126. Shi T, 2015, J GLOB HEALTH, V5, P122, DOI 10.7189/jogh.05.010408
  127. Sonderegger-Iseli K, 2000, LANCET, V355, P2027, DOI 10.1016/S0140-6736(00)02349-7
  128. Spellberg B, 2013, NEW ENGL J MED, V368, P299, DOI 10.1056/NEJMp1215093
  129. Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
  130. Staton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144971
  131. Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640
  132. Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25362
  133. Takahashi S, 2015, SCIENCE, V347, P1240, DOI 10.1126/science.aaa3438
  134. Tapp Christine, 2008, Confl Health, V2, P1, DOI 10.1186/1752-1505-2-1
  135. Thomas B, 2015, J AM SOC NEPHROL, V26, P2621, DOI 10.1681/ASN.2014101017
  136. Traffic general directorate, SPAN ROAD SAF STRAT
  137. United Nations Department of International Economic and Social Aff airs, 1982, MOD LIF TABL DEV COU
  138. United Nations Development Programme, 2016, HUM DEV REP 2015
  139. United Nations High Commissioner for Refugees, UNHCR TOT NUMB SYR R
  140. United Nations Office on Drugs and Crime, 2013, GLOB STUD HOM 2013 T
  141. [Anonymous], INTR UNICEFS WORK ST
  142. National Center for Health Statistics (US), 1991, 1993 NAT MORT FOLL S
  143. Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
  144. Walker PGT, 2015, LANCET INFECT DIS, V15, P825, DOI 10.1016/S1473-3099(15)70124-6
  145. Wallis BA, 2015, INJURY PREV, V21, P195, DOI 10.1136/injuryprev-2014-041216
  146. Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9
  147. Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X
  148. Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1
  149. WHO, 2014, ANT RES GLOB REP SUR
  150. World Health Organization, 2013, WHO METH DAT SOURC G
  151. World Health Organization, NUMB DEATHS 1000S DA
  152. [Anonymous], EST 2000 2015
  153. World Health Organization, 2014, GLOB REP DROWN PREV
  154. [Anonymous], DENG VACC RES
  155. WHO, 2014, WHO METH DAT SOURC C
  156. WHO, 2005, WHO STAT 1 M INT HLT
  157. World Health Organization (WHO), 2015, GLOB TUB REP 2015
  158. World Health Organization (WHO), 2014, WHO MORT DAT VERS FE
  159. [Anonymous], EST 2000 2012
  160. Xie XF, 2016, AM J KIDNEY DIS, V67, P728, DOI 10.1053/j.ajkd.2015.10.011
  161. Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6
  162. [Anonymous], 2015, FIRS CALLS CONTINUED

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - LIM/20
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/16